TRIM21 inhibition alleviates acute kidney injury by promoting INTS3-associated DNA damage repair
Apoptosis · 2026
DOI: 10.1007/s10495-026-02420-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2026. Verfasst von Xinyi Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Minhang Hospital & Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, DNA Repair, DNA Damage, Ribonucleoproteins. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Minhang Project of the Shanghai Science and Technology Commission, Minhang District Medical System Major Discipline Construction Project, Top research project of Minhang Hospital, Fudan University.
Abstract (Originalsprache)
Acute kidney injury (AKI) is a common and severe clinical complication with limited treatment options. TRIM21, an E3 ubiquitin ligase, was previously shown to be upregulated in ischemia/reperfusion (I/R)-induced AKI. This study further revealed its role in DNA damage repair. Here, we demonstrated that TRIM21 expression is elevated in human kidney biopsies, murine AKI models, and injured renal tubular epithelial cells (TECs), in parallel with increased DNA double-strand breaks (DSBs). TRIM21 knockout attenuated renal injury, improved renal function, and decreased TECs apoptosis. Mechanistically, TRIM21 was found to bind to INTS3 and facilitate its proteasomal degradation, suppressing DNA repair and promoting apoptosis. INTS3 overexpression alleviated cisplatin-induced DNA damage and apoptosis in TECs. Through virtual screening and activity evaluation, SB33-0223 was identified as a small-molecule inhibitor targeting the C-terminal PRYSPRY domain of the TRIM21 protein. By blocking the recruitment of antibody-bound substrates, SB33-0223 effectively prevents TRIM21-mediated ubiquitination and degradation of INTS3, thereby enhancing INTS3 stability and reducing DNA damage in vitro and in vivo. Our study discovered SB33-0223 as an inhibitor of TRIM21 for the first time, highlighting the TRIM21/INTS3 axis as a critical regulator of DNA repair in AKI, supporting SB33-0223 as a promising lead for targeted therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Minhang Hospital & Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
- Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
- Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China.
- School of Pharmacy, East China Normal University, Shanghai, 200062, China. xmzhang@pharm.ecnu.edu.cn.
- Department of Pathology, Minhang Hospital & Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China. xiaolixie_919@fudan.edu.cn.
- Department of Pathology, Minhang Hospital & Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China. xinhong@fudan.edu.cn.
ORCID-Profile: Hong Xin
Förderung
- Minhang Project of the Shanghai Science and Technology Commission
- Minhang District Medical System Major Discipline Construction Project
- Top research project of Minhang Hospital, Fudan University
Zitieren
APA
Dong, X., Zhuang, S., Zhang, J., Zhao, Z., Sheng, X., Li, Y., Zhang, X., Xie, X., & Xin, H. (2026). TRIM21 inhibition alleviates acute kidney injury by promoting INTS3-associated DNA damage repair. Apoptosis. https://doi.org/10.1007/s10495-026-02420-0
Vancouver
Dong X, Zhuang S, Zhang J, Zhao Z, Sheng X, Li Y, et al. TRIM21 inhibition alleviates acute kidney injury by promoting INTS3-associated DNA damage repair. Apoptosis. 2026. doi:10.1007/s10495-026-02420-0
BibTeX
@article{Dong2026,
author = {Dong, Xinyi and Zhuang, Shaoyong and Zhang, Jianing and Zhao, Zhilong and Sheng, Xia and Li, Yan and Zhang, Xuemei and Xie, Xiaoli and Xin, Hong},
title = {TRIM21 inhibition alleviates acute kidney injury by promoting INTS3-associated DNA damage repair},
journal = {Apoptosis},
year = {2026},
doi = {10.1007/s10495-026-02420-0}
}
EUVIMED